| HOME >> BIOLOGY >> TECHNOLOGY |
Stockholders' equity:
Common stock 14,196 14,132
Additional paid-in capital 104,899,820 103,524,814
Other comprehensive income 57,165 5,286
Accumulated deficit (72,505,779) (67,307,730)
Total stockholders' equity 32,465,402 36,236,502
Total liabilities and
stockholders' equity $40,608,649 $46,071,496
ATRICURE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Six Months Ended June 30,
2008 2007
Cash flows from operating activities:
Net loss $(5,198,047) $(7,089,511)
Adjustments to reconcile net loss to
net cash used in operating activities:
Depreciation and amortization 1,423,711 1,046,280
Loss on disposal of equipment - 6,852
Provision for (benefit from) losses
in accounts receivable 12,397 (99,720)
Share-based compensation expense 1,142,123 882,999
Changes in assets and liabilities,
excluding effects of acquired business:
Accounts receivable (2,192,408) (585,842)
Inventories (556,362) (586,742)
Other current assets 92,879 255,872
Accounts payable and accrued
liabilities (1,234,568) 293,955
Other non-current assets and
liabilities
'/>"/>
| SOURCE AtriCure, Inc. Copyright©2008 PR Newswire. All rights reserved |